Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0890-6238(96)00212-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool.
J Cancer Educ
August 2022
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, Room 1611, New York, NY, 10032, USA.
Growing evidence links adolescent exposures to cancer risk later in life, particularly for common cancers like breast. The adolescent time period is also important for cancer risk reduction as many individual lifestyle behaviors are initiated including smoking and alcohol use. We developed a cancer risk-reduction educational tool tailored for adolescents that focused on five modifiable cancer risk factors.
View Article and Find Full Text PDFBiomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
Allergy
December 2020
Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland.
Modern health care requires a proactive and individualized response to diseases, combining precision diagnosis and personalized treatment. Accordingly, the approach to patients with allergic diseases encompasses novel developments in the area of personalized medicine, disease phenotyping and endotyping, and the development and application of reliable biomarkers. A detailed clinical history and physical examination followed by the detection of IgE immunoreactivity against specific allergens still represents the state of the art.
View Article and Find Full Text PDFBackground: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Allergists and other healthcare providers (HCPs) in the field of allergies and associated airway diseases are on the front line, taking care of patients potentially infected with SARS-CoV-2. Hence, strategies and practices to minimize risks of infection for both HCPs and treated patients have to be developed and followed by allergy clinics.
View Article and Find Full Text PDFImmune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Allergy
July 2020
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute-phase reactants, and serum biochemistry in COVID-19.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!